Geneos Wealth Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.53M | Sell |
|
|||||
|
2025
Q2 | $893K | Sell |
|
|||||
|
2025
Q1 | $1.04M | Buy |
|
|||||
|
2024
Q4 | $502K | Buy |
|
|||||
|
2024
Q3 | $971K | Sell |
|
|||||
|
2024
Q2 | $890K | Sell |
|
|||||
|
2024
Q1 | $977K | Sell |
|
|||||
|
2023
Q4 | $685K | Sell |
|
|||||
|
2023
Q3 | $801K | Sell |
|
|||||
|
2023
Q2 | $607K | Sell |
|
|||||
|
2023
Q1 | $898K | Sell |
|
|||||
|
2022
Q4 | $491K | Sell |
|
|||||
|
2022
Q3 | $725K | Sell |
|
|||||
|
2022
Q2 | $626K | Buy |
|
|||||
|
2022
Q1 | $764K | Sell |
|
|||||
|
2021
Q4 | $995K | Sell |
|
|||||
|
2021
Q3 | $1.87M | Sell |
|
|||||
|
2021
Q2 | $1.56M | Sell |
|
|||||
|
2021
Q1 | $2.26M | Buy |
|
|||||
|
2020
Q4 | $961K | Buy |
|
|||||
|
2020
Q3 | $101K | Hold |
|
|||||
|
2020
Q2 | $108K | Sell |
|
|||||
|
2020
Q1 | $80K | Sell |
|
|||||
|
2019
Q4 | $126K | Sell |
|
|||||
|
2019
Q3 | $160K | Sell |
|
|||||
|
2019
Q2 | $220K | Sell |
|
|||||
|
2019
Q1 | $284K | Sell |
|
|||||
|
2018
Q4 | $224K | Hold |
|
|||||
|
2018
Q3 | $358K | Buy |
|
|||||
|
2018
Q2 | $78K | Sell |
|
|||||
|
2018
Q1 | $196K | Sell |
|
|||||
|
2017
Q4 | $245K | Buy |
|
|||||
|
2017
Q3 | $146K | Buy |
|
|||||
|
2017
Q2 | $149K | Buy |
|
|||||
|
2017
Q1 | $130K | Buy |
|
|||||
|
2016
Q4 | $51K | Buy |
|
|||||
|
2016
Q3 | $57K | Hold |
|
|||||
|
2016
Q2 | $77K | Hold |
|
|||||
|
2016
Q1 | $73K | Buy |
|